Elodie Long-Mira Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge Université Côte d’Azur Biography Publications Institution JoVE Articles Elodie Long-Mira has not added a biography. If you are Elodie Long-Mira and would like to personalize this page please email our Author Liaison for assistance. Publications Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma Cancers. Sep, 2018 | Pubmed ID: 30216999 Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? Cancers. Jun, 2018 | Pubmed ID: 29966305 [Carcinoma of Unknown Primary. Case No. 5] Annales De Pathologie. Jun, 2018 | Pubmed ID: 29929746 [Carcinoma of Unknown Primary. Case No. 6] Annales De Pathologie. Jun, 2018 | Pubmed ID: 29929745 [Carcinoma of Unknown Primary. Role of the Pathologist in 2018: Introduction] Annales De Pathologie. Jun, 2018 | Pubmed ID: 29929740 Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections Through the Encapsulation of Dried DNA Cancers. Jun, 2018 | Pubmed ID: 29891792 Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site Cancers. Apr, 2018 | Pubmed ID: 29621151 Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients Cancers. Mar, 2018 | Pubmed ID: 29561830 Any Place for Immunohistochemistry Within the Predictive Biomarkers of Treatment in Lung Cancer Patients? Cancers. Mar, 2018 | Pubmed ID: 29534030 Expression of MET in Circulating Tumor Cells Correlates with Expression in Tumor Tissue from Advanced-stage Lung Cancer Patients Oncotarget. Apr, 2017 | Pubmed ID: 28212540 Met behulp van 22C 3 Anti-PD-L1 antilichaam concentreren op biopsie en cytologie monsters van niet-kleincellige longkanker kankerpatiënten Marius Ilié1,2,3, Mélanie Ngo-Mai1, Elodie Long-Mira1,2, Sandra Lassalle1,2, Catherine Butori1, Coraline Bence1, Marame Hamila1, Véronique Hofman1,2,3, Paul Hofman1,2,3 1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur, 2Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur, 3Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur JoVE 58082 Cancer Research
Met behulp van 22C 3 Anti-PD-L1 antilichaam concentreren op biopsie en cytologie monsters van niet-kleincellige longkanker kankerpatiënten Marius Ilié1,2,3, Mélanie Ngo-Mai1, Elodie Long-Mira1,2, Sandra Lassalle1,2, Catherine Butori1, Coraline Bence1, Marame Hamila1, Véronique Hofman1,2,3, Paul Hofman1,2,3 1Laboratory of Clinical and Experimental Pathology, Pasteur Hospital, Hospital University Federation OncoAge, Université Côte d’Azur, 2Institute for Research on Cancer and Aging in Nice (Inserm U1081 and CNRS 7284), Université Côte d’Azur, 3Hospital-Integrated Biobank (BB-0033-00025), Pasteur Hospital, Université Côte d’Azur JoVE 58082 Cancer Research
